Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and caffeic acid phenethyl ester

phorbol 12,13-dibutyrate has been researched along with caffeic acid phenethyl ester in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Chen, TG; Chou, DS; Lee, JJ; Lin, KH; Shen, CH; Sheu, JR1

Other Studies

2 other study(ies) available for phorbol 12,13-dibutyrate and caffeic acid phenethyl ester

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.
    The Chinese journal of physiology, 2007, Jun-30, Volume: 50, Issue:3

    Topics: Blood Platelets; Caffeic Acids; Cell Adhesion Molecules; Cyclic AMP; Cyclic GMP; Humans; Microfilament Proteins; Phenylethyl Alcohol; Phorbol 12,13-Dibutyrate; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Thromboembolism

2007